A Study In Patients With Type 2 Diabetes Mellitus

Summary

This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.

Timeline

Start

2005-08-18

Primary completion

2006-10-31

Completion

2006-10-31

Outcome

Met primary endpoint

registry All FDC RSG/SIMV Groups vs All RSG Monotherapy Groups; p <0.0001; Ratio Expressed as percent difference -37.186 (95% CI -41.219 to -32.879); ANCOVA NCT00256867 ↗

Drugs

Indications